A Study to Demonstrate Bioequivalence Between 6 x 2 mg Tablets of Perampanel and a Single 12 mg Tablet of Perampanel in Healthy Subjects

Clinical trial NCT01240187 · COMPLETED

Trial details

NCT number: NCT01240187
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Partial Onset Epilepsy

Start date: 2010-06-01
Primary completion: 2010-09-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.